1-3 of 3
Christos Vaklavas, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I, Multicenter, Open Label, Dose Escalation of 90 yttrium-Ibritumomab Tiuxetan Radioimmunotherapy Using a Modified Regimen for Relapsed or Refractory Follicular or Transformed CD20+ B-Cell Lymphoma

Christos Vaklavas, MD, Ruby F Meredith, M.D., Ph.D., Susan J. Knox, MD, PhD, Gregory Wiseman, MD, Thomas E. Witzig, MD, Ivana N. Micallef, MD, Albert F. Lobuglio, MD, Andres Forero, MD
Journal: Blood
Blood (2011) 118 (21): 1648.
https://doi.org/10.1182/blood.V118.21.1648.1648
Published: 2011
Journal Articles

Pediatric Therapy-Related Myelodysplastic Syndrome/Acute Myeloid Leukemia: The M. D. Anderson Cancer Center Experience

Dolly G Aguilera, Christos Vaklavas, MD, Apostolia-Maria Tsimberidou, MD, PhD, Sijin Wen, PhD, L. Jeffrey Medeiros, MD, Seth J. Corey
Journal: Blood
Blood (2008) 112 (11): 5068.
https://doi.org/10.1182/blood.V112.11.5068.5068
Published: 2008
Journal Articles

’Idiopathic’ Eosinophilia with an Occult T-Cell Clone: Prevalence, FIP1L1-PDGFRA Status, and Clinical Course.

Animesh Pardanani, MD, PhD, Christos Vaklavas, MD, Joseph Butterfield, MD, Rhett Ketterling, MD, Srdan Verstovsek, MD, PhD, Hagop Kantarjian, MD, Ayalew Tefferi, MD
Journal: Blood
Blood (2006) 108 (11): 2701.
https://doi.org/10.1182/blood.V108.11.2701.2701
Published: 2006